UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Fluorescent stains for quantification of DNA by confocal laser scanning microscopy in 3-D

Biotechnic & histochemistry, 2008-03, Vol.83 (2), p.63-69

2008

Volltextzugriff (PDF)

546: Localization and Distribution of Micro-RNAs in the Myocardium of Heart Failure Patients before and after LVAD Support

The Journal of heart and lung transplantation, 2010-02, Vol.29 (2), p.S177-S178

2010

Volltextzugriff (PDF)

Interleukin-2 in cancer treatment : disappointing or (still) promising ? a review

Cancer Immunology, Immunotherapy, 1993-05, Vol.36 (3), p.141-148

1993

Volltextzugriff (PDF)

Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2

Cancer research (Chicago, Ill.), 1989-12, Vol.49 (24), p.7037-7040

1989

Volltextzugriff (PDF)

Intratumoral low-dose interleukin-2 induces rejection of distant solid tumour

Cancer Immunology, Immunotherapy, 1991-11, Vol.33 (6), p.389-394

1991

Volltextzugriff (PDF)

Interleukin-2-containing liposomes : interaction of interleukin-2 with liposomal bilayers and preliminary studies on application in cancer vaccines

Pharmaceutical research, 1993-12, Vol.10 (12), p.1715-1721

1993

Volltextzugriff (PDF)

Human natural killer cells: a convenient purification procedure and the influence of cryopreservation on cytotoxic activity

Journal of immunological methods, 1993-09, Vol.165 (1), p.21-30

1993

Volltextzugriff (PDF)

The glycosylation profile of interleukin-2 activated human lymphocytes correlates to their anti-tumor activity

Anticancer research, 1996-01, Vol.16 (1), p.155

1996

Volltextzugriff (PDF)

Effect of immunomodulators on specific tumor immunity induced by liposome‐encapsulated tumor‐associated antigens

International journal of cancer, 1994-03, Vol.56 (5), p.721-726

1994

Volltextzugriff (PDF)

Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study

European Journal of Nuclear Medicine, 2001-06, Vol.28 (6), p.743-749

2001

Volltextzugriff (PDF)

The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice

Cancer Immunology, Immunotherapy, 1986-10, Vol.23 (2), p.113-118

1986

Volltextzugriff (PDF)

Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in mice

Cancer Immunology, Immunotherapy, 1993-09, Vol.37 (4), p.271-279

1993

Volltextzugriff (PDF)

Macrophages and antitumor reactions

Cancer Immunology, Immunotherapy, 1983-01, Vol.16 (2), p.67-71

1983

Volltextzugriff (PDF)

Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells

Cancer Immunology Immunotherapy, 1992-07, Vol.34 (4), p.233-240

1992

Volltextzugriff (PDF)

A survey of some formal models in tumor immunology

Cancer Immunology, Immunotherapy, 1986-12, Vol.23 (3), p.159-164

1986

Volltextzugriff (PDF)

Transfer of tumor immunity by both CD4 + and CD8 + tumor infiltrating T lymphocytes activated in vivo by IL-2 therapy of tumor bearing mice

Immunobiology (1979), 1993-07, Vol.188 (3), p.281-292

1993

Volltextzugriff (PDF)

Cancer treatment with interleukins 1, 4 and 6 and combinations of cytokines: a review

In vivo (Athens), 1991-11, Vol.5 (6), p.567

1991

Volltextzugriff (PDF)

Mechanisms of tumor regression induced by low doses of interleukin-2

In vivo (Athens), 1991-11, Vol.5 (6), p.637

1991

Volltextzugriff (PDF)

Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection

Cancer Immunology, Immunotherapy, 1989, Vol.30 (1), p.28-33

1989

Volltextzugriff (PDF)

Tumour regression by IL-2 mediated stagnation of blood flow

In vivo (Athens), 1991-11, Vol.5 (6), p.679

1991

Volltextzugriff (PDF)

Effective immunotherapy with local low doses of interleukin-2

In vivo (Athens), 1991-11, Vol.5 (6), p.561

1991

Volltextzugriff (PDF)

Initial immunochemical characterization of specific macrophage-arming factor

Cancer Immunology, Immunotherapy, 1989-01, Vol.30 (1), p.21-27

1989

Volltextzugriff (PDF)

Higher ADCC of murine peritoneal cells after immunization with allogenic tumor cells as compared with stimulation by adriamycin, BCG, and thioglycolate

Cellular immunology, 1986-09, Vol.101 (2), p.454-462

1986

Volltextzugriff (PDF)

Acid Ethanol Fixation and Polyester Wax Embedding Combines Preservation of Antigenic Determinants with Good Morphology and Enables Simultaneous Bromodeoxyuridine (BRDU) Labeling

Biotechnic & histochemistry, 1991, Vol.66 (2), p.55-62

1991

Volltextzugriff (PDF)

Therapy with allogeneic immune peritoneal cells

Cancer research (Chicago, Ill.), 1974-07, Vol.34 (7), p.1726-1730

1974

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(66)

Sprache

Englisch
(66)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Animals
(39)
Life Sciences & Biomedicine
(37)
Mice
(33)
Mice, Inbred Dba
(25)
Immunology
(19)
Biological And Medical Sciences
(18)
Oncology
(18)
Medical Sciences
(16)
Immunotherapy
(15)
Humans
(14)
Macrophages - Immunology
(13)
Cytotoxicity, Immunologic
(12)
Physical Sciences
(10)
Antineoplastic Agents
(9)
Neoplasms, Experimental - Immunology
(9)
Pharmacology. Drug Treatments
(9)
Lymphoma - Immunology
(8)
Lymphoma - Therapy
(8)
Physics
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fluorescent stains for quantification of DNA by confocal laser scanning microscopy in 3-D

546: Localization and Distribution of Micro-RNAs in the Myocardium of Heart Failure Patients before and after LVAD Support

Interleukin-2 in cancer treatment : disappointing or (still) promising ? a review

Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2

Intratumoral low-dose interleukin-2 induces rejection of distant solid tumour

Interleukin-2-containing liposomes : interaction of interleukin-2 with liposomal bilayers and preliminary studies on application in cancer vaccines

Human natural killer cells: a convenient purification procedure and the influence of cryopreservation on cytotoxic activity

The glycosylation profile of interleukin-2 activated human lymphocytes correlates to their anti-tumor activity

Effect of immunomodulators on specific tumor immunity induced by liposome‐encapsulated tumor‐associated antigens

Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study

The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice

Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in mice

Macrophages and antitumor reactions

Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells

A survey of some formal models in tumor immunology

Transfer of tumor immunity by both CD4 + and CD8 + tumor infiltrating T lymphocytes activated in vivo by IL-2 therapy of tumor bearing mice

Cancer treatment with interleukins 1, 4 and 6 and combinations of cytokines: a review

Mechanisms of tumor regression induced by low doses of interleukin-2

Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection

Tumour regression by IL-2 mediated stagnation of blood flow

Effective immunotherapy with local low doses of interleukin-2

Initial immunochemical characterization of specific macrophage-arming factor

Higher ADCC of murine peritoneal cells after immunization with allogenic tumor cells as compared with stimulation by adriamycin, BCG, and thioglycolate

Acid Ethanol Fixation and Polyester Wax Embedding Combines Preservation of Antigenic Determinants with Good Morphology and Enables Simultaneous Bromodeoxyuridine (BRDU) Labeling

Therapy with allogeneic immune peritoneal cells

Aktive Filter

Suchergebnisse filtern